Drug-Related Side Effects and Adverse Reactions
"Drug-Related Side Effects and Adverse Reactions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.
Descriptor ID |
D064420
|
MeSH Number(s) |
C25.100
|
Concept/Terms |
Drug-Related Side Effects and Adverse Reactions- Drug-Related Side Effects and Adverse Reactions
- Drug Related Side Effects and Adverse Reactions
- Side Effects of Drugs
- Drug Side Effects
- Drug Side Effect
- Effects, Drug Side
- Side Effect, Drug
- Side Effects, Drug
- Adverse Drug Reaction
- Adverse Drug Reactions
- Drug Reaction, Adverse
- Drug Reactions, Adverse
- Reactions, Adverse Drug
- Adverse Drug Event
- Adverse Drug Events
- Drug Event, Adverse
- Drug Events, Adverse
Drug Toxicity- Drug Toxicity
- Toxicity, Drug
- Drug Toxicities
- Toxicities, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug-Related Side Effects and Adverse Reactions".
Below are MeSH descriptors whose meaning is more specific than "Drug-Related Side Effects and Adverse Reactions".
This graph shows the total number of publications written about "Drug-Related Side Effects and Adverse Reactions" by people in this website by year, and whether "Drug-Related Side Effects and Adverse Reactions" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 | 1997 | 1 | 0 | 1 | 1999 | 1 | 0 | 1 | 2000 | 0 | 2 | 2 | 2001 | 3 | 0 | 3 | 2002 | 1 | 0 | 1 | 2004 | 2 | 1 | 3 | 2005 | 1 | 0 | 1 | 2006 | 3 | 4 | 7 | 2007 | 1 | 6 | 7 | 2008 | 0 | 5 | 5 | 2009 | 0 | 4 | 4 | 2010 | 1 | 1 | 2 | 2011 | 4 | 3 | 7 | 2012 | 5 | 5 | 10 | 2013 | 8 | 9 | 17 | 2014 | 4 | 2 | 6 | 2015 | 9 | 4 | 13 | 2016 | 5 | 5 | 10 | 2017 | 7 | 9 | 16 | 2018 | 14 | 4 | 18 | 2019 | 4 | 5 | 9 | 2020 | 14 | 1 | 15 | 2021 | 5 | 3 | 8 | 2022 | 13 | 1 | 14 | 2023 | 12 | 1 | 13 | 2024 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug-Related Side Effects and Adverse Reactions" by people in Profiles.
-
Texidor WM, Miller MA, Molina KC, Krsak M, Calvert B, Hart C, Storer M, Fish DN. Oritavancin as sequential therapy for Gram-positive bloodstream infections. BMC Infect Dis. 2024 Jan 24; 24(1):127.
-
Kyler KE, Hall M, Antoon JW, Goldman J, Shah SS, Tang Girdwood S, Williams DJ, Feinstein JA. Major Drug-Drug Interaction Exposure Among Medicaid-Insured Children in the Outpatient Setting. Pediatrics. 2024 Jan 01; 153(2).
-
Stempel DA, Szefler SJ. Is the assessment of asthma treatment efficacy sufficiently comprehensive? J Allergy Clin Immunol. 2024 Mar; 153(3):629-636.
-
Rosenberg A, Waller JD, Szeto MD, Pulsipher KJ, Bloomfield CA, Presley CL, Dellavalle RP. Tocilizumab Treatment in COVID-19 Patients: Comparing Cutaneous Disease and Adverse Drug Effects. J Drugs Dermatol. 2023 12 01; 22(12):e42-e43.
-
Boyd CM, Shetterly SM, Powers JD, Weffald LA, Green AR, Sheehan OC, Reeve E, Drace ML, Norton JD, Maiyani M, Gleason KS, Sawyer JK, Maciejewski ML, Wolff JL, Kraus C, Bayliss EA. Evaluating the Safety of an Educational Deprescribing Intervention: Lessons from the Optimize Trial. Drugs Aging. 2024 Jan; 41(1):45-54.
-
Goldberg EM, Dresden SM, Carpenter CR. Clin-STAR corner: Practice changing advances in prescribing for geriatric emergency department patients. J Am Geriatr Soc. 2023 12; 71(12):3686-3691.
-
Green HH, Ray L, Buchanan J, Matsler N. Urinary retention and mydriasis secondary to topical glycopyrronium for axillary hyperhidrosis. Am J Health Syst Pharm. 2023 09 07; 80(18):1234-1237.
-
Davis SR, Pinkerton J, Santoro N, Simoncini T. Menopause-Biology, consequences, supportive care, and therapeutic options. Cell. 2023 09 14; 186(19):4038-4058.
-
Dart RC, Mullins ME, Matoushek T, Ruha AM, Burns MM, Simone K, Beuhler MC, Heard KJ, Mazer-Amirshahi M, Stork CM, Varney SM, Funk AR, Cantrell LF, Cole JB, Banner W, Stolbach AI, Hendrickson RG, Lucyk SN, Sivilotti MLA, Su MK, Nelson LS, Rumack BH. Management of Acetaminophen Poisoning in the US and Canada: A Consensus Statement. JAMA Netw Open. 2023 08 01; 6(8):e2327739.
-
King-Kallimanis BL, Calvert M, Cella D, Cocks K, Coens C, Fairclough D, Howie L, Jonsson P, Mahendraratnam N, Maues J, Sarac S, Shaw J, Stigger N, Trask P, Wieseler B. Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials. Value Health. 2023 10; 26(10):1543-1548.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|